biotech - search results
If you're not happy with the results, please do another search
How Are Second Quarter Corporate Earnings Faring?
I was recently a part of a great panel for MarketWatch talking about corporate earnings season so far. Sital Patel was the moderator and...
Semiconductors: Is the Charge About to Die?
In striking contrast to 2014's dominant theme of "record low volatility" and the numbingly granular tedium with which it has been analyzed, some US...
Take A Long, Hard Look at the Russell 2000
In the wake of Fed Chairwoman Janet Yellen's allusions during her Senate testimony today to a "reach for yield" and "isolated pockets" of valuations stretched...
Universal Collapse: Charts To Watch During The Summer Doldrums
With another 4th of July past, stocks now formally enter that wretchedly inert season known as "The Summer Doldrums". Ordinarily, this is the most...
5 Charts To Watch This Week
The U.S. financial markets appear to be as groggy as its investors returning from the long weekend. A quick scan of the futures market brings...
Small Cap Stocks In Focus: Russell 2000 Resistance Looms Large
The first sign of relative weakness in the equities market showed up in the form of risk-off for high beta stocks. These included small cap...
Celgene (CELG) At Technical Crossroads
Despite the excitement surrounding the S&P 500 briefly touching all-time highs on Monday, the market has yet to demonstrate proper follow-thru or confirmation that...
Market Masters: How Standing On Your Head Can Reduce Investor Bias
by Chris Kimble Warren Buffett famously said he’s not a fan of technical analysis because he got the same answer when he...
Why Is the Market Playing Defense At All-Time Highs?
Yesterday we examined the medium and long-term outlook of the major US equity indices, laying out the thesis that the nascent weakness in the Russell...
The Best Of See It Market – March 2014
On the surface, March appeared to come and go with little investor fanfare. However, when peeling back the onion, it was a much more...
